A citation-based method for searching scientific literature

Haakon B Nygaard. Biol Psychiatry 2018
Times Cited: 58







List of co-cited articles
587 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
Adam C Kaufman, Santiago V Salazar, Laura T Haas, Jinhee Yang, Mikhail A Kostylev, Amanda T Jeng, Sophie A Robinson, Erik C Gunther, Christopher H van Dyck, Haakon B Nygaard,[...]. Ann Neurol 2015
171
44

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.
Lars M Ittner, Yazi D Ke, Fabien Delerue, Mian Bi, Amadeus Gladbach, Janet van Eersel, Heidrun Wölfing, Billy C Chieng, MacDonald J Christie, Ian A Napier,[...]. Cell 2010
34

Fyn kinase inhibition as a novel therapy for Alzheimer's disease.
Haakon B Nygaard, Christopher H van Dyck, Stephen M Strittmatter. Alzheimers Res Ther 2014
100
32

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Ji Won Um, Haakon B Nygaard, Jacqueline K Heiss, Mikhail A Kostylev, Massimiliano Stagi, Alexander Vortmeyer, Thomas Wisniewski, Erik C Gunther, Stephen M Strittmatter. Nat Neurosci 2012
420
31

Phosphorylation of tau by fyn: implications for Alzheimer's disease.
Gloria Lee, Ramasamy Thangavel, Vandana M Sharma, Joel M Litersky, Kiran Bhaskar, Sandy M Fang, Lana H Do, Athena Andreadis, Gary Van Hoesen, Hanna Ksiezak-Reding. J Neurosci 2004
289
27

The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease.
Megan Larson, Mathew A Sherman, Fatou Amar, Mario Nuvolone, Julie A Schneider, David A Bennett, Adriano Aguzzi, Sylvain E Lesné. J Neurosci 2012
195
22

Tau interacts with src-family non-receptor tyrosine kinases.
G Lee, S T Newman, D L Gard, H Band, G Panchamoorthy. J Cell Sci 1998
328
20

Regulation of NMDA receptors by the tyrosine kinase Fyn.
Catherine H Trepanier, Michael F Jackson, John F MacDonald. FEBS J 2012
121
18

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.
Haakon B Nygaard, Allison F Wagner, Garrett S Bowen, Susan P Good, Martha G MacAvoy, Kurt A Strittmatter, Adam C Kaufman, Brian J Rosenberg, Tomoko Sekine-Konno, Pradeep Varma,[...]. Alzheimers Res Ther 2015
77
18

Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
Ji Won Um, Adam C Kaufman, Mikhail Kostylev, Jacqueline K Heiss, Massimiliano Stagi, Hideyuki Takahashi, Meghan E Kerrisk, Alexander Vortmeyer, Thomas Wisniewski, Anthony J Koleske,[...]. Neuron 2013
357
17

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
M P Lambert, A K Barlow, B A Chromy, C Edwards, R Freed, M Liosatos, T E Morgan, I Rozovsky, B Trommer, K L Viola,[...]. Proc Natl Acad Sci U S A 1998
17

Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease.
Jeannie Chin, Jorge J Palop, Jukka Puoliväli, Catherine Massaro, Nga Bien-Ly, Hilary Gerstein, Kimberly Scearce-Levie, Eliezer Masliah, Lennart Mucke. J Neurosci 2005
250
17

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial.
Christopher H van Dyck, Haakon B Nygaard, Kewei Chen, Michael C Donohue, Rema Raman, Robert A Rissman, James B Brewer, Robert A Koeppe, Tiffany W Chow, Michael S Rafii,[...]. JAMA Neurol 2019
42
23

Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice.
Jeannie Chin, Jorge J Palop, Gui-Qiu Yu, Nobuhiko Kojima, Eliezer Masliah, Lennart Mucke. J Neurosci 2004
131
15

Src family kinases: modulators of neurotransmitter receptor function and behavior.
Hiroshi Ohnishi, Yoji Murata, Hideki Okazawa, Takashi Matozaki. Trends Neurosci 2011
68
15


Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
Lars M Ittner, Jürgen Götz. Nat Rev Neurosci 2011
816
13

Fyn, a Src family tyrosine kinase.
M D Resh. Int J Biochem Cell Biol 1998
100
13

Tau-targeting therapies for Alzheimer disease.
Erin E Congdon, Einar M Sigurdsson. Nat Rev Neurol 2018
322
13

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
François Piette, Joël Belmin, Hélène Vincent, Nicolas Schmidt, Sylvie Pariel, Marc Verny, Caroline Marquis, Jean Mely, Laurence Hugonot-Diener, Jean-Pierre Kinet,[...]. Alzheimers Res Ther 2011
85
12

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.
Erik D Roberson, Brian Halabisky, Jong W Yoo, Jinghua Yao, Jeannie Chin, Fengrong Yan, Tiffany Wu, Patricia Hamto, Nino Devidze, Gui-Qiu Yu,[...]. J Neurosci 2011
440
12

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Juha Laurén, David A Gimbel, Haakon B Nygaard, John W Gilbert, Stephen M Strittmatter. Nature 2009
12

Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice.
S G Grant, T J O'Dell, K A Karl, P L Stein, P Soriano, E R Kandel. Science 1992
908
12

Neuropathological stageing of Alzheimer-related changes.
H Braak, E Braak. Acta Neuropathol 1991
12

An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients.
Ebbe T Poulsen, Filomena Iannuzzi, Helle F Rasmussen, Thorsten J Maier, Jan J Enghild, Arne L Jørgensen, Carmela Matrone. Front Mol Neurosci 2017
16
43


Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor.
T Nakazawa, S Komai, T Tezuka, C Hisatsune, H Umemori, K Semba, M Mishina, T Manabe, T Yamamoto. J Biol Chem 2001
363
12

Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.
Nikhil Panicker, Hariharan Saminathan, Huajun Jin, Matthew Neal, Dilshan S Harischandra, Richard Gordon, Kavin Kanthasamy, Vivek Lawana, Souvarish Sarkar, Jie Luo,[...]. J Neurosci 2015
85
12

The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
10

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
Dawn H W Lau, Marte Hogseth, Emma C Phillips, Michael J O'Neill, Amy M Pooler, Wendy Noble, Diane P Hanger. Acta Neuropathol Commun 2016
41
14

Fyn-tau-amyloid: a toxic triad.
Christian Haass, Eckhard Mandelkow. Cell 2010
67
10


Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
Dominic M Walsh, Igor Klyubin, Julia V Fadeeva, William K Cullen, Roger Anwyl, Michael S Wolfe, Michael J Rowan, Dennis J Selkoe. Nature 2002
8

Fyn, a potential target for Alzheimer's disease.
Kai Yang, Jillian Belrose, Catherine H Trepanier, Gang Lei, Michael F Jackson, John F MacDonald. J Alzheimers Dis 2011
35
14


N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor.
Laurent F Hennequin, Jack Allen, Jason Breed, Jon Curwen, Michael Fennell, Tim P Green, Christine Lambert-van der Brempt, Rémy Morgentin, Richard A Norman, Annie Olivier,[...]. J Med Chem 2006
233
8

Structure and regulation of Src family kinases.
Titus J Boggon, Michael J Eck. Oncogene 2004
460
8

Tau in physiology and pathology.
Yipeng Wang, Eckhard Mandelkow. Nat Rev Neurosci 2016
761
8

Disease-related modifications in tau affect the interaction between Fyn and Tau.
Kiran Bhaskar, Shu-Hui Yen, Gloria Lee. J Biol Chem 2005
169
8


Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction.
Luca Rosario La Rosa, Lorena Perrone, Morten Schallburg Nielsen, Pietro Calissano, Olav Michael Andersen, Carmela Matrone. Front Cell Neurosci 2015
22
22

APP is phosphorylated by TrkA and regulates NGF/TrkA signaling.
Carmela Matrone, Alessia P M Barbagallo, Luca R La Rosa, Fulvio Florenzano, Maria T Ciotti, Delio Mercanti, Moses V Chao, Pietro Calissano, Luciano D'Adamio. J Neurosci 2011
47
10

Tyr682 in the Aβ-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance.
Carmela Matrone, Siro Luvisetto, Luca R La Rosa, Robert Tamayev, Annabella Pignataro, Nadia Canu, Li Yang, Alessia P M Barbagallo, Fabrizio Biundo, Franco Lombino,[...]. Aging Cell 2012
28
17

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
I Grundke-Iqbal, K Iqbal, Y C Tung, M Quinlan, H M Wisniewski, L I Binder. Proc Natl Acad Sci U S A 1986
8

miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Wei Liu, Jingya Zhao, Guangxiu Lu. Biochem Biophys Res Commun 2016
34
14

Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules.
Robin White, Constantin Gonsior, Eva-Maria Krämer-Albers, Nadine Stöhr, Stefan Hüttelmaier, Jacqueline Trotter. J Cell Biol 2008
131
8


Fyn kinase in brain diseases and cancer: the search for inhibitors.
S Schenone, C Brullo, F Musumeci, M Biava, F Falchi, M Botta. Curr Med Chem 2011
48
10

PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.
T Tezuka, H Umemori, T Akiyama, S Nakanishi, T Yamamoto. Proc Natl Acad Sci U S A 1999
315
8

A phase II trial of tideglusib in Alzheimer's disease.
Simon Lovestone, Mercè Boada, Bruno Dubois, Michael Hüll, Juha O Rinne, Hans-Jürgen Huppertz, Miguel Calero, María V Andrés, Belén Gómez-Carrillo, Teresa León,[...]. J Alzheimers Dis 2015
224
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.